Biosion, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis (NCT05932654) | Biosion, Inc. | 2023-07-31 |
| Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis (NCT05114889) | Biosion, Inc. | 2021-10-25 |
Track Biosion, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.